期刊文献+

单纯形网格法优化设计姜黄素-胡椒碱复方自微乳制剂处方 被引量:12

Optimization and characterization of curcumin-piperine dual drug loaded self-microemulsifying drug delivery system by simplex lattice design
原文传递
导出
摘要 该研究的目的在于制备姜黄素-胡椒碱复方自微乳给药系统(Cur-PIP-SMEDDS),并对其质量进行评价。该研究通过选择合适的油相、表面活性剂和助表面活性剂,以姜黄素和胡椒碱为模型药物,采用单纯形网格法优化设计Cur-PIPSMEDDS处方;以乳剂的载药量、平均粒径为评价指标,通过Design Expert 8.06软件进行试验设计和模型构建,响应面数据分析优化和验证最佳处方组成。通过观察微乳外观和微观形态并测定其粒径、电位、包封率及载药量对其进行质量评价。结果显示优化得Cur-PIP-SMEDDS最佳处方为丙二醇单辛酸酯(Capryol 90)-聚氧乙烯氢化蓖麻油(Cremophor RH40)-二乙二醇单乙基醚(Transcutol HP)(10∶60∶30),所形成的微乳外观澄清、透明,呈圆球型,粒径分布均匀,平均粒径为(15.33±0.80)nm,姜黄素和胡椒碱的载药量分别为40.90,0.97 mg·g-1,包封率分别为94.98%,90.96%。研究表明Cur-PIP-SMEDDS可以显著改善姜黄素的水溶性和稳定性,有望提高姜黄素的口服生物利用度,以期为其剂型开发提供新的思路和方法,进而促进其在临床上的应用。 The objective of the study was to prepare and evaluate the quality of curcumin-piperinedual drug loaded self-microemulsifying drug delivery system(Cur-PIP-SMEDDS). Simplex lattice design was constructed using optimal oil phase, surfactant and cosurfactant concentration as independent variables, and the curcumin and piperine were used as model drugs to optimize Cur-PIP-SMEDDS formulation. In the present study, the drug loadings of curcumin and piperine, mean particle size of Cur-PIP-SMEDDS were made as indicators, and the experiment design, model building and response surface analysis were established using Design Expert 8.06 software to optimize and verify the composition of SMEDDS formulation. The quality of Cur-PIP-SMEDDS was evaluated by observing the appearance status, transmission electron microscope micrographs and determining particle diameter, electric potential, drug entrapment efficiency and drug loading of it. As a result, the optimal formulation of SMEDDS was CapryoL 90-Cremophor RH40-TranscutoL HP(10:60:30). The appearance of Cur-PIP-SMEDDS remained clarified and transparent, and the microemulsion droplets appeared spherical without aggregation with uniform particle size distribution. The mean size of microemulsion droplet formed from Cur-PIP-SMEDDS was 15.33 nm, the drug loading of SMEDDS for Cur and PIP were 40.90 mg·g^-1 and 0.97 mg·g^-1, respectively, the drug entrapment efficiency were 94.98% and 90.96%, respectively. The results show that Cur-PIP-SMEDDS can increase the solubility and stability of curcumin significantly, in the expectation of enhancing the bioavailability of it. Taken together, these findings can provide the reference to a preferable choice of the Cur formulation and contribute to therapeutic application in clinical research.
出处 《中国中药杂志》 CAS CSCD 北大核心 2014年第20期3936-3944,共9页 China Journal of Chinese Materia Medica
基金 国家自然科学基金项目(30801549) 北京中医药大学复方中药制剂研究创新团队发展计划项目(2011-CXTD-13) 北京中医药大学自主选题项目(2014-JYBZZ-XS-087)
关键词 单纯形网格法 姜黄素 胡椒碱 自微乳给药系统 处方优化 质量评价 simplex lattice design curcumin piperine SMEDDS formulation optimization quality evaluation
  • 相关文献

参考文献38

  • 1Witkin J M, Li X. Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: some uses and the establishment and biological basis of medical efficacy[J].CNS Neurol Disord Drug Targets,2013, 12(4):487.
  • 2Shehzad A, Rehman G, Lee Y S. Curcumin in inflammatory diseases[J].Biofactors, 2013, 39(1): 69.
  • 3Ali T, Shakir F, Morton J. Curcumin and inflammatory bowel disease: biological mechanisms and clinical implication[J].Digestion, 2012,85(4):249.
  • 4Lim T G, Lee S Y, Huang Z, et al.Curcumin suppresses proliferation of colon cancer cells by targeting CDK2[J].Cancer Prev Res (Phila), 2014,7(4):466.
  • 5Terlikowska K, Witkowska A, Terlikowski S.Curcumin in chemoprevention of breast cancer[J].Postepy Hig Med Dosw, 2014,68:571.
  • 6Ahmad N, Umar S, Ashafaq M, et al. Acomparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke[J].Protoplasma, 2013, 250(6): 1327.
  • 7Kalani A, Kamat P K, Kalani K, et al. Epigenetic impact of curcumin on stroke prevention[J].Metab Brain Dis, 2014, doi:10.1007/s11011-014-9537-0.
  • 8Chin D, Huebbe P, Pallauf K, et al. Neuroprotective properties of curcumin in Alzheimer\'s disease——merits and limitations[J].Curr Med Chem, 2013, 20(32):3955.
  • 9Wang Y, Yin H, Wang L,et al. Curcumin as a potential treatment for Alzheimer\'s disease: a study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein[J].Am J Chin Med,2013, 41(1):59.
  • 10Yang J, Song S, Li J, et al. Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson\'s disease rat [J].Pathol Res Pract, 2014 , 210(6): 357.

二级参考文献24

  • 1仲明远,全山丛,胡晋红.姜黄素制剂学研究进展[J].中成药,2007,29(2):255-258. 被引量:16
  • 2温彩霞,许建华,黄秀旺,张昆仲.姜黄素在荷瘤小鼠体内各组织的分布及药物动力学研究[J].中药新药与临床药理,2007,18(3):219-221. 被引量:5
  • 3刘屏,索婧侠,于腾飞.胡椒碱药理作用的研究进展[J].中国药物应用与监测,2007,4(3):7-9. 被引量:46
  • 4Kyatanwar A U, Jadhav K R, Kadam V J. Self micro-emulsifying drug delivery system (SMEDDS): Review [J]. J Pharm Res, 2010, 3 (1) : 75 -83.
  • 5Patel D, Sawant K K. Sell micro-emulsifying drug delivery system : for- mulation development and biopharmaeeutieal evaluation of lipophilie drugs[J]. Curr Drug Deliv, 2009, 6(4) : 419 -424.
  • 6Wei J D, Ho H O, Chen C H, et al. Characterisation of fenofibrate dissolution delivered by a sell-mieroemulsifying drug-delivery system [J]. J Pharm Pharmacol, 2010, 62(12) : 1685 -1696.
  • 7Mezghrani O, Ke X, Bourkaib N, et al. Optimized sell-mieroemulsify- ing drug delivery systems (SMEDDS) for enhanced oral bioavailability of astilbin[ J]. Pharmazie, 2011, 66(10) : 754 -760.
  • 8Guo F, Zhong H, He J, et al. Self-mieroemulsifying drug delivery sys- tem for improved oral bioavailability of dipyridamole: preparation and evaluation[J]. Arch Pharm Res, 2011, 34(7) : 1113 -1123.
  • 9Wang Y, Sun J, Zhang T, et al. Enhanced oral bioavailability of ta- crolimus in rats by self-microemulsifying drug delivery systems [ J ]. Drug Dev Ind Pharm, 2011, 37(10) : 1225 -1230.
  • 10Setthacheewakul S, Mahattanadul S, Phadoongsombut N, et al. Devel- opment and evaluation of self-microemulsifying liquid and pellet formu- lations of curcumin, and absorption studies in rats [ J ]. Eur J Pharm Biopharm, 2010, 76(3) : 475 -485.

共引文献22

同被引文献96

引证文献12

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部